AG Jackley: SD won't hand over execution drug to FDA
SIOUX FALLS (AP) -- Attorney General Marty Jackley says South Dakota will work with the U.S. Food and Drug Administration to alleviate concerns over the state's batch of a lethal injection drug but has no plans to turn over the drug.
Jackley wrote a letter to the FDA on Tuesday after the agency requested earlier this month that the state hand over its sodium thiopental stock.
Sodium thiopental is an anesthetic used to put inmates to sleep before other lethal drugs are administered.
South Dakota obtained a stock of the drug from a foreign supplier after the drug's U.S. manufacturer announced last year that it would no longer produce it.
Jackley noted in the letter that the drug was properly cleared by federal authorities through customs and has been independently tested.